References: Silva, Silas Arandas Monteiro E et al
Pills dont require cold supply chains, which do not exist at scale in many regions
This, in turn, can restrict or competitively inhibit SSADH activity, indirectly influencing GABA metabolism (Kilian et al
The FLOW trial, a double-blind, placebo-controlled study examining renal outcomes in patients with type 2 diabetes and chronic kidney disease, demonstrated that semaglutide reduced the progression of kidney disease by 24% compared to placebo
However, route selection, administration hierarchies, documentation requirements, HCPCS drug reporting, and payer rules can quickly complicate the process